Completed PHASE3 INTERVENTIONAL 3-arm NCT02658721

Effects of Systemic or Adjunct Tramadol Addition to Lidocaine Used for IVRA in Patients Undergoing Hand Surgery

Effects of Addition of Systemic Tramadol or Adjunct Tramadol to Lidocaine Used for Intravenous Regional Anesthesia in Patients Undergoing Hand Surgery

Sponsor: Bagcilar Training and Research Hospital

Conditions Anesthesia

Interventions Atropine Diclofenac sodium Ephedrine Fentanyl Lidocaine Midazolam Ondansetron lidocaine+adjunct tramadol lidocaine+systemic tramadol

Updated 6 times since 2017 Last updated: Jan 15, 2016 Started: Jan 31, 2013 Primary completion: Jun 30, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Anesthesia, this trial is completed. The trial is conducted by Bagcilar Training and Research Hospital and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bagcilar Training and Research Hospital

Data source: Bagcilar Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.